Vaccines protect against a large spectrum of infections. The eradication of deadly smallpox in the past and lately the declining statistics of polio are the most wonderful examples of the effect of the vaccine on humans. Here are some of the most promising vaccines on their way in 2018. Continue reading.. Total Word Counts: 1431
Pfizer’s investigational agent, lorlatinib, a next-generation ALK/ROS1 tyrosine kinase inhibitor received Priority Review status from the US FDA for the treatment of patients with ALK-positive metastatic non-small cell lung cancer (NSCLC)....continue reading
New treatment option- anti-CGRP drugs, to prevent a migraine is expected to reach the market in 2018. Allergan’s anti-CGRP candidate, ubrogepant – first oral candidate showed positive outcomes in late-stage clinical development.